newsfilter
← Latest News
PR Newswire·

Neurotronic Announces First Clinical Outcomes of Multi‑Organ Denervation for Type 2 Diabetes and Hypertension

Neurotronic, Inc., a developer of multi-organ denervation to treat complex cardiovascular and metabolic disease, announced today the upcoming...